Evaluation of fluticasone [flixonase] nasal spray versus beclomethasone [beconase] nasal spray in the treatment of allergic rhinitis

ABSTRACT

Although response to intranasal steroid therapy has been reported in patients with allergic rhinitis, efficacy of some nasal steroids is noteworthy. This study was undertaken to evaluate the efficacy of a two-week course of Fluticasone [Flixonase] nasal spray vs. Beclomethasone [Beconase] nasal spray in patients with symptoms of allergic rhinitis referred to our clinic. This study reviewed sixty randomized studies with symptoms of allergic rhinitis which supported common aeroallergens with skin prick test. Patients received a total daily dose of nasal spray of Fluticasone [Flixonase] 100 mcg bid [N=30] compared with patients with allergic rhinitis who received a total daily dose of Beclomethasone [Beconase] 50mcg 2 puffs bid [N=30] patients were visited before and after therapy, and efficacy of flixonase and beconase was evaluated by the change in nasal symptoms including nasal discharge, nasal obstruction, nasal itching, and sneezing. After two weeks of treatment nasal symptoms of blockage, discharge, sneezing and itching were significantly better in the group treated with fluticasone nasal spray 65%, 82%, 67%, 79% respectively [p<0.001] but after treatment with beconase nasal spray lower benefits in the nasal symptoms includes 50%, 71%, 51%, 57% respectively. After two weeks of treatment no deleterious changes consequent to therapy were observed in nasal symptoms. 100 mcg bid flixonase [Fluticasone] intranasal spray is more effective than 50 mcg 2 puffs bid beconase [Beclomethasone] intranasal spray. Like asthma, allergic rhinitis is an inflammatory disease and should be managed with anti-inflammatory medication